The event has been reported with a delay due to our retrospective examination of the record.At the time (2018-07-25) the complaint was reviewed and found not to be reportable.Current day, we compared the record with equivalent events, and found an inconsistency with the reporting decisions.With the current knowledge and the current team of complaint handlers, we have come to conclude the event should have been reported.As a remedial effort, we will report it within capa # (b)(4).Maquet cardiopulmonary (b)(4) was received the product back for investigation.During the visual examination of the sterile bag several damages, also a hole in the foil, were noticed on the clear side.On the paper side of the sterile packaging also a hole was found.The sterility of the packed in the sterile bag blutport cap tight is therefore not possible.No defects were found on the bc 140 plus.The complaint was also investigated by getinge cp antalya.Investigation shows that the failure could be occurred during packaging process and not be noticed by operators.Operators may not be careful about visual controls.Also regarding similar issues mcp ag has been initiated a capa-(b)(4) based on several complaints showing the same symptoms with different material numbers than the one in this complaint, in order to determine the root cause and initiate further actions to determine corrective measures for the failure.According to the received information by an r&d engineer: possible cause, which needs to verify with ongoing packaging test, design/ material of current sterile bag of the tight cap.Possible action design/ material change into an tyvek based blister packaging.Therefore in this case two possible causes are could be determined.It is hard to determine the exact cause of the failure.Rc1: packaging failure during production.Rc2: material/design failure.Device history record was reviewed.There were no references found, which are indicating a nonconformance of the product in question.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.
|